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Genetic Toxicology of Phthalate Esters:
Mutagenic and Other Genotoxic Effects
by George R. Douglas,* Alida P. Hugenholtz,*t and David
H. Blakey*
The effects of DEHP on sperm morphology and on peripheral blood micronuclei were studied for 12
weeksfollowingfivesubacuteIPinjections ofDEHPat1/6,¼/12,and16o oftheLD50perday. Spermmorphology
was examined in both adult mice and rats, while peripheral blood micronuclei were scored in mice up to
4 weeks after treatment. In mice, DEHP at 1/6 LD50 significantly depressed body weight gain for up to 12
weeks after treatment, and reduced epididymal sperm number by 4 weeks. Numbers of morphologically
abnormal sperm did not differ from controls in the 12 weeks following treatment. In addition, DEHP did
not increase the numbers of peripheral blood micronuclei.
Studies in the rat indicated that exposure to doses of1/6 and /12 ofthe LD50 per day ofDEHP resulted in a
reduced gain in body weight compared to controls. Testis weight, sperm number, and numbers of mor-
phologically abnormal sperm were unaffected by DEHP following treatment. In separate experiments,
DEHP did not induce sister chromatid exchange (SCE) or DNA damage in Chinese hamster ovary (CHO)
cells. Although DEHP is known to cause testicular atrophy in rats and to a lesser extent in mice, it did
not cause an increase in abnormal sperm in either species. Together with the CHO and micronucleus data,
these findings suggest that DEHP has a low probability of causing genetic damage capable of being
transmitted through the male germ line.
Introduction
A valid decision on the genotoxicity of phthalates, as
with any chemical substance, requires data from a care-
fully chosen battery oftests. Such abatterywould ideally
contain tests for the two basic types of genetic effects
(i.e., gene mutations and chromosomal mutations) with
redundancy in terms of cell type or organisms where
practicable. In terms ofmaking any decisions concerning
potential hazard to human beings, it is imperative to
recognize that the results ofin vitro tests can only dem-
onstrate the potential to cause the critical effects invivo.
Thus, the actual confirmation of any in vitro effects re-
quires the conduct ofthe appropriate in vivo tests.
Table 1 is a representative, but not necessarily ex-
haustive, summary of studies which have been reported
in the scientific literature on the genotoxicity of phthal-
ates. While it is difficult to generalize about a broad
chemical class, certain observations can be made. The in
vitro and in vivo data are equivocal and give no clear-
cut indication ofgenotoxicity. Where redundancy in end-
points with the same chemical does exist, there is often
a lack of agreement. Discrepancies in the in vivo tests
do not seemtobedue todifferences inthe route ofadmin-
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istration, since both chromosome aberrations and domi-
nant lethality are observed after topical, subcutaneous,
or intraperitoneal injection, as well as following oral
administration.
There are extensive data on a number of other indi-
cators oftoxicity, many ofwhich are discussed elsewhere
in this issue. Examples of some of these effects which
relate to the purpose ofthis paper are shown in Table 2.
Apart from the indication ofliver tumors and teratogen-
icity, which may or may not be related to the genotoxic
effects observed, there is clear evidence of cytotoxicity
both in vitro and in vivo; the most important perhaps
being testicular cell damage (Table 3). Such effects ap-
pear to be related to the age and species as well as to
the route of administration.
Because the existing data suggested agenotoxic effect
and the clear evidence oftesticular damage, we reasoned
that one ofthe most appropriate tests for further study
of the potential genotoxic effects of phthalic acid esters
would be the sperm abnormality assay (39). A number
of carcinogens and mutagens are known to induce ab-
normal sperm morphology, and some abnormalities are
inherited by the offspring oftreated males (39,40). How-
ever, in addition, increased temperature and food dep-
rivation are also known to induce abnormally shaped
sperm (41,42). We have conducted a study on both mice
and rats using DEHP as a representative phthalate. In
order to assist in the determination of the cause of anyDOUGLAS, HUGENHOLTZ, AND BLAKEY
Table 1. Survey of reported genotoxic effects of phthalate esters.
Test
Gene mutation
Chromosome
aberrations
SCE
Dominant lethality
Phthalate
DEHP
DHP
DIBP
MEHP
DEHP
MEHP
DBP
BBP
DMIP
DMTP
DMP ortho esters
DEP
20 phthalates and
related chemicals
MEHP
DEHP
DMP
DEP
DAP
DBP
DOP
DEHP
DEHA
2-ethylhexanol
DIDP
DIBP
MEHP
DEHP
DEHP (oral)
MEHP
DEHP
DBP
DEHP
MEHP
2-ethylhexanol
DEHP
DBP
DEP
DMP
DEHP
DMP (topical)
MEHP
DEHP
DBP
MEHP
DEHP (IP)
DMEP (IP)
DEHP (oral)
MEHP (oral)
DEHP (sc)
Organism
Salmonella typhimurium strains TA 1535, 100,
1537, 1538, 98
S. typhimur-ium strains TA 1535, 100, 1537, 1538,
98
S. typhimurium strains TA 98, 100 (modified)
S. typhimurium strains TA 1535, 100, 1537, 1538,
98 (preincubation)
S. typhimurium strain TA 100
E. coli strain WPI
S. typhimurium strain TA100
S. typhimurium strain TA 100 (liquid suspension
assay)
CHO cells HGPRT-
locus
Mouse lymphoma L5178Y TK +"- locus
Syrian golden hamster embryonic cells
(in vivolin vitro)
Chinese hamster
Don cells
CHO cells
Human leukocytes in culture
Human fetal lung in culture
Rat hepatocytes
Syrian hamster V79 cells
Syrian golden hamster embryonic cells
(in vivo/in vitro)
Chinese hamster Don cells
CHO cells
ICR mouse
Mouse
Mouse
Result
- (+S9)
- (±S9)
- (+S9)
- (±S9)
- (±S9)
- (±S9)
- (±S9)
- (+S9)
- (+S9)
- (+S9)
+ (-S9)
+ (-S9)
- (+S9)
+ (- S9)
+ (-S9)
+ (+S9)
+ (+S9)
+ (+S9)
- (±S9)
+ (±S9)
- (+S9)
- (±S9)
- (±S9)
+ (+S9)
- (+S9)
- (+S9)
inconsistent
+1- (-S9)
- (±S9)
- (-S9) -(-5S9)
+ (-S9)
+1- (-S9)
- (-S9)
tori (10)
Reference
Simon et al. (1)
Ruddick et al. (2)
Kozumbo et al. (3)
Zeiger et al. (4)
Tomita et al. (5)
Seed (6)
Phillips et al. (7)
Kirby et al. (8)
Tomita et al. (5)
Abe and Sasaki (9)
Phillips et al. (7)
Tsuchiya and Hat
- (-S9) Stenchever et al.
(11)
+ (multiple
doses)
- (single dose)
+ (+S9)
+
+ (not dose
+ related)
Yurchenko (12)
Tomita et al. (5)
Abe and Sasaki (9)
Phillips et al. (7)
+ (over 12 wks) Singh et al.
+ (lst 3 wks)
- (over 6 wks) Hamano et;
- (over 6 wks)
+ (preimplant.) Autian (15)
(13)
al. (14)
aAbbreviations forTables: DEHP, di-(2-ethylhexyl) phthalate; DHP, dihexylphthalate; DIBP, diisobutylphthalate; DIDP, diisodecylphthal-
ate; MEHP, mono-(2-ethylhexyl) phthalate; DBP, dibutyl phthalate; BBP, butyl benzyl phthalate; DMIP, dimethyl isophthalate; DMTP,
dimethyl terephthalate; DMP, dimethyl phthalate; DEP, diethyl phthalate; PA, phthalic acid; DAP, diallyl phthalate; DEHA, di (2-ethylhexyl)
adipate; DPeP, di-n-pentyl phthalate; DPP, dipropyl phthalate; DMEP, dimethoxyethyl phthalate.
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Table 2. Some reported cytotoxic, teratogenic and carcinogenic effects of phthalate esters.
Test Phthalate Organism Result Reference
Cytotoxicity 9 phthalates Rat cerebellum fibroblasts +/- (high mw, low H20 Teranishi and
solubility is most toxic) Kazuya (16)
DMEP Replicating mouse L cells + Dillingham and
Autian (17)
DEHP L cells Gesler (18)
DMP +
Various phthalates ?
DEHP CHO cells Phillips et al. (7)
MEHP +
2-Ethylhexanol +
DEHP Chick embryo cells + Lee and Kalmus (19)
DEHP Chick embryo Gesler (18)
DMP +
Various phthalates +/-
DEHP Aquatic invertebrates +/- (low toxicity, high Saunders et al. (20)
DBP +/- excretion rate)
Embryotoxicity DEHP (diet) ICR mouse + Shiota et al. (21)
DBP + (low birth weight)
Teratogenicity DEHP (diet) ICR mouse + (skeletal neural tube Shiota et al. (21)
DBP + malform.)
DEHP (oral) Mouse d7-8 + (gross Yagi et al. (22)
MEHP + and skeletal)
DEHP (IP) Rat - (skeletal) Singh et al. (23)
DMP (IP) + (skeletal)
DMEP (IP) + (skeletal)
MEHP (gavage) Rat d6-15 + (fetotoxicity) Ruddick et al. (2)
Phthalates (yolk sac) Chick embryo various effects Haberman et al. (24)
Carcinogenicity DEHP (diet) F344 rat + (hepatocellular NTP (25)
B6CSFj mouse + carcinomas)
DMTP (diet) F344 rat; B6C3F1 mouse Equivocal NTP (26)
DAP (gavage) B6C3Fj mouse NTP (27)
DEHA (diet) B6C3Fj mouse + (hepatocellular carcinomas) NTP (28)
F344 rat - (toxic liver effects)
Phthalamide B6C3Fj mouse - (urinary toxicity, no tumors) NTP (29)
Phthalic anhydride F344 rat, B6C3F1 mouse - NTP (30)
effects of sperm morphology in the mouse study, circu-
lating red blood cells were assayed for the presence of
micronuclei (43), the products ofa subset ofchromosomal
damage. In separate in vitro experiments with CHO
cells, the effect of DEHP on the formation of SCE and
the induction of alkaline sucrose gradient-detectable
DNA lesions were also determined.
Methods and Materials
Mice of hybrid strain B6C3F1 and Sprague-Dawley
strain rats were obtained from Charles River Breeders
(Lasalle, Quebec). Mice were 6 to 8 weeks old and
weighed 18 to 25 g when treated, while rats ofthe same
age weighed 300 to 375 g when injected. Subacute IP
injections of DEHP (Cat. #D20,115-4; Aldrich, Milwau-
kee, WI) in olive oil (#3016; Eastman Kodak, Rochester,
NY; or Fisher Scientific, Fair Lawn, NJ) were admin-
istered to each animal, along with untouched and solvent
negative controls, and MMS (methyl methanesulfonate;
#7936, Eastman Kodak, Rochester, NY), in normal sa-
line as a positive control. The groups consisted of three
animals (rats) or five animals (mice) per control group
per week and five animals per treatment group perweek.
Animals were injected onfive consecutive days with max-
imum volumes of0.2 mL/mouse and 2.5mL/rat. Doses of
DEHP administered were as follows: mice, 6.0g/kg/day
(1/6LD50),3.0g/kg/day(¼/12LD50),0.6g/kg/day('/60LD50);rats;
5.2 g/kg/day (1/6 LD50), 2.6 g/kg/day (/12 LD50), 0.52g/kg/
day (1/60 LD50). MMS was administered at 75 mg/kg/day
for the positive control mice. Since several mice were lost
during the course of the study, rats were exposed to 75
mg/kg/day on the first injection day, but to 37.5 mg/kg/
day on the remaining four treatment days. The "week 0"
group of animals was sacrificed following the injections
on the 5th day oftreatment and every 2 weeks thereafter
for up to 12 weeks. Mice were sacrificed by cervical dis-
location and rats by CO2 asphyxiation.
Body weights and testes weights were recorded at
sacrifice, and epididymal sperm smears stained in 1%
eosin Y were prepared according to Wyrobek and Bruce
(39), except that rat epididymes were minced in 10 mL
of PBS per cauda. Sperm number was obtained using a
hemacytometer. 500 sperm or more were scored for ab-
normalities per animal. Data are presented as the means
for each treatment group, and analyzed using the G-test
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Table 3. Some reported testicular effects of phthalate esters.
Phthalate Organism Result Parameter Reference
DEHP Rat + atrophy Gangolli (31)
DBP
MBP
DEHP Mouse
DBP
DEHP Guinea pig
DBP
DEHP Hamster - atrophy
DBP
DMP Rat
DPP Rat + atrophy
DHP Rat atrophy
DEHP (IP or SC) Adult mouse - testis weight, Zn Curto and Thomas (32)
Adult rat + testis weight, Zn
MEHP (IP or SC) Adult mouse - testis weight, Zn
Adult rat + testis weight, Zn
DEHP (diet) Immature mouse + testis weight, Zn Oishi (30)
DEHP (oral) 4-wk-old rat + testis weight, Zn Gray and Butterworth (34)
10-wk-old-rat
15-wk-old-rat
DEHP (IP) Immature rat + atrophy Seth et al. (35)
DEHP (diet) Prepubertal rat + atrophy, testis weight Oishi and Hirage (36)
DBP
DIBP
PA
DBP (oral) Prepubertal rat + atrophy and Zn Foster et al. (37)
DPeP
DHP
DPeP (gavage) Prepubertal rat + Sertoli cell enzymes, atrophy Creasy et al. (38)
or Students's t-test (44).
In the mouse experiment, 1000 monochromatic eryth-
rocytes/animal were scored for the presence of micron-
uclei from the 0, 2, and 4 week groups according to the
method described by Schlegel and MacGregor (43).
SCE and alkaline sucrose gradient-detectable DNA
damage was detected in CHO cells as described previ-
ously (45). Cells weretreatedfor 1 hourinminimal MEM
minus calf serum with DEHP dissolved in DMSO.
Results
DNA Damage and SCE in CHO Cells
No increase in the level of SCE (Table 4) or in DNA
damage detectable by alkaline sucrose gradient analysis
(Table 5) was observed after treatment of CHO cells.
Body Weights and Gross Changes
Mice exposed to the highest dose of DEHP (6.0 g/kg/
day) showed significant reductions in body weight gain
(t-test; p < 0.05) compared with other treatment groups
and with control groups at the second sacrifice and con-
tinuingfor the duration ofthe study (p < 0.01) (Fig. la).
A decline in body weight gain was also seen in rats for
12 weeks after exposure to 5.25 g/kg/day (p < 0.01) or
Table 4. Effect of DEHP on SCE in CHO cells.
SCE/cell
Concentration, mM +S9 -S9
0 6.72 6.96
0.01 7.05
0.05 - 6.75
0.1 6.53 7.17
0.5 7.13 7.03
1.0 7.16 6.80
3.0 7.57
6.0 6.73
10.0 6.43
3.0 DMN 20.8
0.5 MMS - 43.5
2.6 g/kg/day (p < 0.05) (Fig. lb). Both species showed
extensive whitish deposits in the diaphragm, abdominal
wall and in the scrotal fat which persisted throughout
the study. In the later weeks, the scrotal sac was filled
with a milky colored fluid in some ofthe high and middle
dose animals from both species.
Peripheral Blood Micronuclei in Mice
Table 6 presents the results obtained when mice ex-
posed to DEHP were sacrificed 0, 2, or 4 weeks after
the final injection. The positive control, MMS, displayed
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Table 5. Effect of DEHP on alkaline sucrose gradient-detectable
DNA damage in CHO cells.
Induced breaks/108 daltons
Concentration, mM +S9 -S9
10.0 0.019 0
30.0 0 0
50.0 0
70.0 0.004 0
100.0 0 0
5.0 DMN 0.965
2.0 MMS 1.895
a significantly (p << 0.001) elevated number ofmicron-
uclei on the day ofsacrifice following the final treatment
(week 0), but levels returned to control values by the
second week. No increase in micronuclei was detected at
any ofthe doses or times following DEHP exposure, nor
with the solvent or untouched control.
Testis Weight
Mice exposed to 6.0 g/kg DEHP per day showed a
decline in testis weight compared to the solvent or un-
NOR MOUSE 10 I I I I
* UNTOUCHED CONTROL /a
:OLIVE OIL,
M *MS 75 f i _d °DEHP 63d/ ,
oDEHP 3o/K4Fda,.
A,DEHP 0.6 g/KgMa
6-
E
4-
z
200 P- S
20-, AL-
A~~~~~~~~~~
2 4 6 8 10
WEEKS AFTER TREATMENT
touched controls by 4 weeks after treatment, but the
decline was not significant (Fig. la) except at 8 weeks
(p < 0.05).
MMS, onthe otherhand, caused asignificant decrease
in testis weight 2 weeks (p < 0.001) and 4 weeks (p <
0.01) aftertreatment, which thenreturned to within nor-
mal range (Fig. la). No such decline in testis weight (p
> 0.05) was seen for any ofthe treatment groups in the
rat as indicated in Figure la.
Sperm Number
Mice exposed to DEHP at 6.0 g/kg/day showed a sig-
nificant reduction in sperm number per epididymis from
4 weeks following exposure to the end ofthe study (p <
0.01) (Fig. la). MMS, on the other hand, showed a re-
versible decline in sperm number, that attained control
values by the final weeks (Fig. la). By 10 weeks after
exposure, sperm numbers in the rats were not signifi-
cantly reduced (p > 0.05) at any of the doses of DEHP
(Fig. lb). A decline in sperm number was not significant
(p > 0.05) following exposure to MMS in the rats.
S.D. RAT
2 4 6 8 V
WEEKS AFTER TREATMENT
FIGURE 1. Effect of exposure to DEHP on body weight gain, testes weight, and sperm number in mice and rats: each point represents the
mean ofthe treatment groups.
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Table 6. Induction of micronuclei in peripheral blood erythrocytes of B6C3F1 male mice given five daily injections of DEHP.
Micronuclei/1000 erythrocytes at various times following final injectionab
Treatment 0 2 weeks 4 weeks
Untouched control 4.60 ± 1.75 (5) 0.75 ± 0.87 (4) 4.60 ± 1.48 (5)
Solvent control 5.00 ±4.29 (4) 3.00 ± 1.49(4) 1.50 ± 1.00 (4)
0.6 g/kg/day DEHP 3.40 ± 1.52 (5) 6.20 ± 1.75 (5) 3.60 ± 0.76 (3)
3.0 g/kg/day DEHP 5.00 ±4.42 (3) 2.80 ± 1.52 (5) 3.17 ± 0.59 (5)
6.0 g/kg/day DEHP 1.20 ± 1.34 (5) 2.00 ± 1.22 (5) 2.80 ± 0.96 (6)
75 mg/kg/day MMS 20.75 ±6.85 (4) 2.00 ± 1.22 (3) 2.33 ± 1.47 (3)
aMicronuclei/1000 ciruclating normochromatic erythrocytes ± standard error of the mean.
bThe numbers in parentheses indicate the number of animals analyzed.
Sperm Morphology
The results of the sperm abnormality studies are
shown in Figure 2. In general, DEHP did not exert strik-
ing increases in the levels of abnormally shaped sperm
in either species, over the 12-week period examined.
Discussion
In this investigation, two in vitro assays were per-
formed with CHO cells to assist in the determination of
genotoxic potential; alkaline sucrose gradient analysis,
which detects a spectrum ofdifferent types ofDNA dam-
80
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age, and the SCE assay, which must be regarded as an
indicator of DNA damage. Accordingly, in the interpre-
tation of these data, it must be realized that neither of
their effects represent mutations per se. Furthermore,
as these are in vitro tests, their results must be tem-
pered with the wisdom ofexperimental data from whole
animal models. The lack of an effect in the peripheral
blood micronucleus assay in mice complements the neg-
ative findings of the in vitro assays.
The sperm abnormality assay performed both in mice
and rats represents a departure from the protocol es-
tablished by Wyrobek and Bruce (39,46), where a single
sacrifice time of 5 weeks following the first treatment
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FIGURE 2. Effect of exposure to DEHP on percentage of morphologically abnormal sperm in mice and rats: each point represents the means of
the treatment groups.
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was employed. In the present study, animals were sac-
rificed every 2 weeks up to 12 weeks following the last
dose. The advantage ofthis protocol can be seen by the
observationthatthepositive control(MMS) produced the
maximum response at 2 weeks in these studies rather
than at approximately 4 weeks. These data demonstrate
that optimal responses can vary from one agent to an-
other, and point out the necessity ofusing multiple sac-
rifice times.
No sperm abnormalities were induced by DEHP in
either mice or rats, even though toxic effects were seen
in the testis (i.e., reduced testis weight and sperm count
in mice) and body weight gains were reduced on both
species. To the extent that abnormal sperm morphology
is an indicator ofgenotoxicity (47), it would appear that
DEHP would have little probability ofcausing inherited
genetic damage in the offspring oftreated animals. The
othernegative datainthis study support this conclusion.
Furthermore, although toxic effects other than muta-
genicityareknowntoinduce spermabnormalities (41,42),
such appears not to be the case with DEHP
The genotoxicity that is observed with phthalates by
others(3,5-7,12,13,15) occursatveryhighconcentrations.
Accordingly, the influences of limited solubility, impuri-
ties, or an indirect genotoxic effect resulting from pri-
mary toxicity should be considered seriously as a caus-
ative factor in these cases. For instance, in Seed's study
(6) of phthalates using bacterial strains of Salmonella
typhimurium, no absolute increases in the mutant fre-
quencies in S. typhimurium treated with a number of
phthalates were observed; increased mutagenicity was
obtained only when data were corrected for viability.
Onthe otherhand, no genotoxicity was observed inthe
present experiments, even at very high, toxic levels of
DEHP. This suggests that toxic effects are not the only
determinants influencing the genotoxic effects ofphthal-
ates in other studies. The contradictoryresults reported
for some assay systems (1,3-6,13-15) suggest that vari-
abilityingeneralexperimental conditions, culturemedia,
cell types or species could account for some of the re-
ported ambiguities.
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